Recombinant atpA fragments have been used to generate antisera for surface localization assays. For example, whole-cell ELISAs with antisera against related ATP synthase subunits (e.g., atpF) showed titers >500,000, confirming surface exposure .
Cross-reactivity: Antisera against atpA may recognize homologous subunits in other streptococcal species, aiding broad-spectrum vaccine design .
Knockout strategies: Homologous recombination methods, similar to those used for spy0895 and spy1536 genes, could be applied to study atpA function. This involves temperature-sensitive plasmids (e.g., pGhost5) and erythromycin selection .
CRISPR-Cas9 systems: Emerging tools for S. pyogenes enable precise atpA deletion or modification, facilitating functional studies .
Structural data: No resolved 3D structures for S. pyogenes atpA exist; predictions rely on homology models from Bacillus or E. coli ATP synthases .
Pathogenic role: While ATP synthase is essential for bacterial survival, its contribution to S. pyogenes virulence is underexplored compared to well-characterized virulence factors like M protein or C5a peptidase .
| Subunit | Gene | Function | Recombinant Production |
|---|---|---|---|
| α | atpA | Catalytic nucleotide binding | Partial (this review) |
| β | atpD | ATP synthesis | Well-characterized |
| b | atpF | Membrane anchoring | Yes (e.g., CSB-YP002358SUQ1) |
KEGG: spf:SpyM51229
ATP synthase in S. pyogenes is a multi-subunit enzyme complex that catalyzes ATP synthesis using energy from the proton gradient across the bacterial membrane. It consists of two domains: F₁ (containing the catalytic core with α, β, γ, δ, and ε subunits) and F₀ (comprising the membrane proton channel with a, b, and c subunits) .
Key differences from human (mitochondrial) ATP synthase:
Bacterial ATP synthases are located in the plasma membrane, while human ATP synthase is in the inner mitochondrial membrane
Different inhibitor sensitivity profiles
Variations in subunit composition and molecular weight
Bacterial ATP synthase often functions in reverse during anaerobic growth to maintain membrane potential
Research considerations: When designing inhibitor studies or structural analyses, these differences are crucial for developing antimicrobial targets that don't affect human ATP synthase.
For recombinant expression of S. pyogenes ATP synthase subunit alpha, several systems have proven effective:
| Expression System | Advantages | Limitations | Tag Options |
|---|---|---|---|
| E. coli | High yield, cost-effective, rapid growth | Lack of post-translational modifications, inclusion body formation | N-terminal His-tag, C-terminal Myc-tag |
| Yeast (S. cerevisiae, P. pastoris) | Better folding, some post-translational modifications | Lower yield than E. coli | N-terminal 10xHis-tag, C-terminal epitope tags |
| Cell-free systems | Avoids toxicity issues, rapid | Expensive, limited scale | Various tags possible |
Methodology notes:
For E. coli expression, BL21(DE3) or Rosetta strains often provide optimal results
Codon optimization is critical due to GC content differences
Growth at lower temperatures (16-25°C) after induction helps reduce inclusion body formation
Consider fusion partners (MBP, SUMO) to enhance solubility if inclusion bodies are problematic
These strategies have been successfully employed for other S. pyogenes proteins (including nucleases and ADP-ribosyltransferases) , suggesting their applicability to ATP synthase subunits.
Purifying recombinant S. pyogenes ATP synthase alpha subunit presents several specific challenges:
Solubility issues: ATP synthase subunits often form inclusion bodies or aggregate during expression
Solution: Screen solubilization buffers with different detergents (0.5-1% Triton X-100, CHAPS, or DDM)
Denaturation/refolding protocols may be necessary
Maintaining native conformation: The alpha subunit's function depends on proper folding
Include ATP or ADP (1-5 mM) in purification buffers to stabilize conformation
Avoid harsh elution conditions when using affinity chromatography
Co-purification of contaminants: Bacterial chaperones often co-purify with ATP synthase subunits
Employ multi-step purification (ion exchange followed by size exclusion chromatography)
Use high salt washes (300-500 mM NaCl) during initial affinity purification steps
Verification of purity: ATP synthase subunit alpha has a similar molecular weight to common contaminants
The recombinant protein should be stored in Tris-based buffer with 50% glycerol at -20°C for extended storage, with aliquoting recommended to avoid freeze-thaw cycles .
Verifying functional integrity requires multiple approaches:
Structural integrity assessment:
Circular dichroism (CD) spectroscopy to confirm secondary structure
Thermal shift assays to assess protein stability
Limited proteolysis to evaluate proper folding
Nucleotide binding analysis:
Fluorescence-based assays using MANT-ATP or TNP-ATP
Isothermal titration calorimetry (ITC) to measure binding affinities
Surface plasmon resonance (SPR) for binding kinetics
ATPase activity assessment:
Colorimetric phosphate release assays (e.g., malachite green assay)
Coupled enzyme assays (with pyruvate kinase and lactate dehydrogenase)
Luciferase-based ATP detection methods
Complex formation evaluation:
Size-exclusion chromatography to assess oligomerization state
Native PAGE to detect complex formation with other ATP synthase subunits
Chemical crosslinking followed by mass spectrometry
When analyzing ATP synthase activity, researchers should establish appropriate positive controls (such as commercially available F₁ ATP synthase) and negative controls (heat-inactivated enzyme) .
ATP synthase plays crucial roles in S. pyogenes adaptation to changing environmental conditions:
pH homeostasis:
Nutritional stress response:
Oxidative stress management:
Biofilm formation:
ATP synthase expression changes during biofilm development
Energy production via ATP synthase supports extracellular polysaccharide synthesis
In vitro experiments demonstrated that ATP synthase is critical for maintaining S. pyogenes viability during transition to stationary phase, with mutant strains showing reduced survival .
Several lines of evidence suggest ATP synthase subunits might be valuable vaccine candidates:
Surface accessibility:
Conservation across strains:
Immunogenicity:
Patients recovering from S. pyogenes infections develop antibodies against numerous cell surface proteins
Convalescent sera from patients with invasive disease recognize surface-exposed proteins including ATP synthase components
ATP synthase subunits are expressed during human infection, as demonstrated by seroconversion
Potential for protective immunity:
Other bacterial ATP synthase components have shown promise as vaccine antigens
Similar approaches with other highly conserved metabolic enzymes have demonstrated protection in animal models
Genetic variation in atpA across S. pyogenes strains has several functional implications:
Sequence conservation and variation:
Functional impacts:
Single nucleotide polymorphisms (SNPs) may alter:
Catalytic efficiency
Thermal stability
pH sensitivity
Interaction with other subunits
Strains adapted to different tissue niches show subtle variations in ATP synthase genes
Expression level differences:
Promoter region variations affect transcription levels
Post-transcriptional regulation varies between strains
Some strains show altered regulation during infection stages
Evolutionary selection:
ATP synthase genes are subject to purifying selection
Mutations affecting core function are typically eliminated
Variations in regulatory regions persist more frequently
A comparative study of S. pyogenes strains showed that while coding sequences are highly conserved, promoter regions and intergenic spaces show more variation, suggesting that expression regulation rather than protein structure is the primary target of evolutionary adaptation .
Robust experimental design for ATP synthase activity studies requires careful consideration of controls:
Essential Controls:
| Control Type | Purpose | Implementation |
|---|---|---|
| Positive control | Verify assay functionality | Commercial F₁-ATPase or well-characterized bacterial ATP synthase |
| Negative controls | Establish baseline and specificity | Heat-inactivated enzyme, buffer-only, irrelevant protein |
| Inhibitor controls | Confirm specificity | DCCD (F₀ inhibitor), oligomycin (F₀ inhibitor), azide (F₁ inhibitor) |
| Substrate controls | Verify substrate specificity | Test GTP, CTP as alternative substrates |
| pH controls | Account for pH effects | Run parallel assays at different pH values (6.5-8.0) |
| Metal ion dependence | Verify cofactor requirements | EDTA treatment, reconstitution with different divalent cations |
Additional validation approaches:
Mutant variants: Create known catalytic site mutants (H225A, H262A) to serve as negative controls
Subunit interactions: Test isolated alpha subunit vs. alpha in complex with beta/other subunits
Time-course measurements: Establish linearity of activity over experimental timeframe
Concentration dependencies: Verify Michaelis-Menten kinetics with varying substrate concentrations
When using spectrophotometric assays, incorporate controls for background absorbance and non-enzymatic hydrolysis of ATP, particularly at extreme pH values or temperatures .
Several complementary techniques can elucidate ATP synthase-protein interactions:
Co-immunoprecipitation (Co-IP):
Use antibodies against atpA to pull down interaction partners
Employ epitope-tagged recombinant atpA (His, FLAG, or HA tags)
Analyze by mass spectrometry to identify binding partners
Verify with reciprocal Co-IP experiments
Surface Plasmon Resonance (SPR):
Immobilize purified atpA on sensor chip
Measure real-time binding kinetics with potential interacting proteins
Determine association/dissociation rates and binding affinities
Can detect weak and transient interactions
Crosslinking coupled with mass spectrometry:
Use chemical crosslinkers (e.g., DSS, formaldehyde) to capture interactions
Apply in vivo crosslinking to capture physiologically relevant interactions
Identify crosslinked peptides by mass spectrometry
Map interaction interfaces at amino acid resolution
Bacterial two-hybrid systems:
Adapt bacterial two-hybrid systems for studying S. pyogenes protein interactions
Use as screening tool to identify novel interaction partners
Verify with other methods
Fluorescence-based methods:
Fluorescence resonance energy transfer (FRET)
Bioluminescence resonance energy transfer (BRET)
Fluorescence correlation spectroscopy (FCS)
Can be applied in vitro or in live cells
Structural biology approaches:
X-ray crystallography of complexes
Cryo-electron microscopy for larger assemblies
NMR for mapping interaction surfaces
Studies using these approaches have identified interactions between ATP synthase subunits and various regulatory proteins in S. pyogenes, including potential links to virulence regulation networks .
Designing effective gene deletion studies for ATP synthase requires specialized approaches:
Selection of target genes:
Complete atpA deletion may be lethal – consider conditional knockouts
Target regulatory genes controlling ATP synthase expression
Create partial deletions or point mutations in critical domains
Consider deleting other ATP synthase subunits that may be less essential
Methodological approaches:
Verification strategies:
PCR verification with primers outside the flanking regions
RT-qPCR to confirm transcriptional changes
Western blotting to verify protein deletion
Whole-genome sequencing to confirm clean deletion and detect potential compensatory mutations
Phenotypic characterization:
Growth curves in different media and stress conditions
ATP production measurement
pH homeostasis assessment
Membrane potential analysis
Virulence in infection models
Competition assays with wild-type strains
Controls and complementation:
Recent successful gene deletion strategies in S. pyogenes employ colE1-type plasmids as suicide vectors, allowing generation of non-polar mutants in just 3 days, with 73-93% success rates for various target genes .
ATP synthase plays multifaceted roles during S. pyogenes infection:
Metabolic adaptation:
Adjusts energy production according to host microenvironments
Responds to fluctuating nutrient availability in different tissues
Coordinates with other metabolic pathways during infection phases
pH tolerance:
Stress response integration:
Biofilm formation:
Contributes to energy requirements during biofilm development
Expression changes coordinate with adhesin production
May influence extracellular matrix composition
Immune evasion connections:
Unexpected surface exposure may contribute to immune interactions
Regulated as part of complex virulence networks
May interact with host factors directly or indirectly
Transcriptomic analysis revealed that F₀F₁-type ATP synthase genes (atpB-H) are downregulated in the presence of arginine, which correlates with upregulation of virulence factors like streptolysin S and streptolysin O, suggesting coordinated regulation between metabolism and virulence .
The ATP synthase alpha subunit from S. pyogenes contains several distinctive structural features:
Domain organization:
N-terminal beta-barrel domain (residues ~1-95)
Central nucleotide-binding domain (residues ~96-380)
C-terminal alpha-helical domain (residues ~381-510)
Key functional regions:
Phosphate-binding loop (P-loop) containing the conserved sequence GXGXGKT/S
DELSEED region (or bacterial equivalent) that interacts with the gamma subunit
Nucleotide-binding pocket with specific metal coordination sites
Species-specific features:
Surface-exposed epitopes unique to S. pyogenes
Specialized interfaces for interaction with other bacterial subunits
Surface residues that may contribute to membrane association
Comparative structural analysis between bacterial and human ATP synthase alpha subunits reveals differences in:
| Feature | S. pyogenes ATP synthase | Human ATP synthase |
|---|---|---|
| Size | ~510 amino acids | ~553 amino acids |
| Metal binding | Primarily Mg²⁺ | Mg²⁺, Ca²⁺, or Mn²⁺ |
| Inhibitor sensitivity | Insensitive to oligomycin | Sensitive to oligomycin |
| Surface properties | More hydrophobic patches | Different surface charge distribution |
| Post-translational modifications | Limited modifications | Multiple modification sites |
These structural differences provide potential targets for selective inhibition and are important considerations for both antimicrobial development and immunological studies .
Several cutting-edge biophysical methods provide insights into ATP synthase dynamics:
Single-molecule techniques:
Single-molecule FRET to monitor conformational changes
Optical tweezers to measure rotational force generation
Magnetic tweezers for torque measurements
High-speed atomic force microscopy to visualize rotational dynamics
Advanced spectroscopic methods:
Hydrogen/deuterium exchange mass spectrometry (HDX-MS) to map conformational dynamics
Electron paramagnetic resonance (EPR) spectroscopy with site-directed spin labeling
Solid-state NMR to study membrane-embedded regions
Time-resolved fluorescence spectroscopy to measure conformational transitions
Structural methods with dynamic information:
Time-resolved cryo-electron microscopy
X-ray free-electron laser (XFEL) crystallography
Molecular dynamics simulations based on structural data
Normal mode analysis of structural ensembles
Functional assays with temporal resolution:
Real-time ATP synthesis/hydrolysis measurements
Simultaneous proton translocation and ATP synthesis monitoring
Patch-clamp electrophysiology to measure proton currents
pH-sensitive fluorescent probes to monitor local pH changes
These methods have revealed that ATP synthase functions as a rotary motor, with the gamma subunit rotating within the alpha/beta hexamer during catalysis. The bacterial ATP synthase completes this rotation in discrete 120° steps, with each step coupled to ATP synthesis or hydrolysis .
Studying membrane-associated ATP synthase presents unique challenges requiring specialized approaches:
Membrane mimetic systems:
Detergent micelles (DDM, CHAPS, OG) for initial extraction
Nanodiscs with defined lipid composition for controlled environment
Liposome reconstitution for functional studies
Amphipols for maintaining native-like environment without detergents
Advanced isolation techniques:
Styrene-maleic acid lipid particles (SMALPs) to extract membrane proteins with native lipids
Digitonin extraction for preserving supercomplexes
Native electrophoresis (BN-PAGE, CN-PAGE) for intact complex analysis
Density gradient ultracentrifugation to separate intact complexes
Functional reconstitution strategies:
Proteoliposome creation with controlled lipid composition
Co-reconstitution with proton pumps to generate proton gradients
Incorporation of pH or voltage sensors
Surface-tethered membranes for single-molecule studies
Structural analysis of membrane complexes:
Cryo-electron microscopy for near-atomic resolution
Electron crystallography for 2D crystals
Solid-state NMR for atomic-level dynamics
X-ray crystallography with lipidic cubic phase
Overcoming expression challenges:
Cell-free expression systems with supplied lipids or detergents
Specialized host strains for membrane protein expression
Fusion with membrane protein expression enhancers
Codon optimization and controlled expression rate
Studies using CN-PAGE with mild detergents have successfully analyzed ATP synthase complexes from bacteria, showing that assembly occurs from separate modules: the c-ring, F₁, and the stator arm. This approach preserves important protein-protein interactions that are disrupted by harsher conditions .
Several specialized approaches can identify selective inhibitors:
High-throughput screening platforms:
ATP hydrolysis assays using purified enzyme
Whole-cell ATP production assays
Growth inhibition screening with counter-screening against human cell lines
Membrane potential-sensitive fluorescent dyes to detect ATP synthase inhibition
Structure-based drug design:
Homology modeling of S. pyogenes ATP synthase
Molecular docking against unique binding pockets
Fragment-based screening approaches
Structure-activity relationship studies of lead compounds
Target-based approaches:
Photoaffinity labeling to identify binding sites
Thermal shift assays to detect stabilizing compounds
Surface plasmon resonance for binding kinetics
Hydrogen-deuterium exchange mass spectrometry to map binding interfaces
Physiological validation:
Membrane potential measurement
Intracellular ATP quantification
Proton translocation assays
Effects on virulence factor expression
Selectivity assessment:
Counter-screening against human ATP synthase
Cytotoxicity evaluation in mammalian cells
Mitochondrial function assays
Cardiac cell contractility assessment
These approaches have successfully identified selective inhibitors of other bacterial ATP synthases, suggesting similar strategies would be effective for S. pyogenes. The goal is to identify compounds that exploit structural differences between bacterial and human enzymes to achieve selective toxicity .
Recombinant ATP synthase subunits offer several advantages for vaccine development:
Antigen preparation approaches:
High-purity recombinant protein production
Engineered constructs focusing on immunogenic epitopes
Fusion with carrier proteins or adjuvants
Multivalent designs incorporating multiple antigens
Immunological considerations:
Surface epitope mapping to identify accessible regions
B-cell and T-cell epitope prediction
Cross-reactivity assessment with human homologs
Evaluation in multiple serotype challenge models
Delivery platforms:
Protein-based subunit vaccines
DNA vaccines encoding optimized sequences
Viral vector delivery systems
mRNA-based approaches
Outer membrane vesicles displaying ATP synthase components
Combination strategies:
ATP synthase components combined with established antigens (e.g., M protein derivatives)
Multi-epitope constructs targeting different virulence factors
Prime-boost regimens with different delivery platforms
Research has shown that other surface-exposed proteins in S. pyogenes can elicit protective immune responses. Proteomic analysis identified ATP synthase F₀F₁ subunit alpha among the surface-associated proteins in S. pyogenes , suggesting it may be accessible to antibodies. The high conservation of ATP synthase across different S. pyogenes strains makes it potentially valuable for broad-spectrum protection .
Several emerging research directions show particular promise:
Systems biology approaches:
Integrating transcriptomics, proteomics, and metabolomics data
Network analysis of ATP synthase interactions with virulence regulation
Flux balance analysis of energy metabolism during infection
Multi-omics analysis across infection stages
In vivo dynamics:
Real-time imaging of ATP production during infection
Single-cell analysis of ATP synthase expression
Tissue-specific metabolic adaptations
Host-pathogen metabolic interactions
Regulatory mechanisms:
Small RNA regulation of ATP synthase expression
Post-translational modifications affecting activity
Protein-protein interactions modulating function
Environmental sensing and signal transduction
Unexpected functions:
Potential moonlighting roles of ATP synthase components
Surface-exposed functions unrelated to ATP synthesis
Interactions with host immune factors
Involvement in biofilm matrix organization
Therapeutic applications:
Attenuated strains through ATP synthase modulation
Metabolic inhibitors as antivirulence compounds
Combination therapies targeting energy production
Host-directed therapies affecting bacterial energy requirements
These approaches may reveal how S. pyogenes coordinates energy production with virulence expression during infection. Recent findings showing coordinated regulation between ATP synthase and virulence factors under arginine-rich conditions highlight the complex integration of metabolism and pathogenesis .
Genetic variation in ATP synthase provides valuable insights into evolutionary processes:
Comparative genomics approaches:
Analysis of ATP synthase sequences across diverse clinical isolates
Correlation with geographical distribution and disease manifestations
Identification of selection signatures
Mapping recombination events affecting ATP synthase genes
Experimental evolution:
Laboratory evolution under different energy stresses
Selection for altered ATP synthase function
Tracking compensatory mutations
Fitness landscape mapping for ATP synthase variants
Structure-function correlations:
Mapping natural variants onto structural models
Identifying functionally important residues under purifying selection
Characterizing the effects of natural variants on enzyme function
Determining structural constraints on evolution
Host adaptation signatures:
Comparing ATP synthase sequences from different host-adapted strains
Identifying adaptive mutations for specific host environments
Correlating genetic variants with tissue tropism
Experimental validation of adaptive hypotheses
Clinical correlations:
Association of ATP synthase variants with disease severity
Correlation with antibiotic resistance profiles
Identification of hypervirulent lineage markers
Development of molecular typing schemes